According to a new report, published by KBV research, The Global Blepharoplasty Market size is expected to reach $5.7 billion by 2028, rising at a market growth of 8.0% CAGR during the forecast period.
The Lower Eyelid segment is showcasing a CAGR of 8.4% during (2022 - 2028). The growing elderly population and the need for less invasive surgical techniques are to blame. Surgery on the lower eyelids removes fat, saggy skin, and excess skin. Moreover, it eliminates eyelid wrinkles, dark circles, and bags beneath the eyes. These are a few of the primary reasons that, throughout the study period, drive both the market for blepharoplasty and the demand for eye surgical treatments.
The Female segment acquired maximum revenue share in the Global Blepharoplasty Market by Gender in 2021 thereby, achieving a market value of $4.4 billion by 2028. This is related to a growing desire to enhance appearance via eye rejuvenation, which makes the eyes seem more young and rejuvenated.
The Clinics segment has shown the growth rate of 8.1% during (2022 - 2028). This is linked to the availability of cutting-edge technology and skilled medical personnel. Patients generally choose outpatient treatments that may be done in dermatological clinics over hospital procedures that might need anesthesia. Outpatient procedures are less intrusive. The fastest-growing market globally is capitalized on by less invasive laser blepharoplasty procedures.
The North America market dominated the Global Blepharoplasty Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2.2 billion by 2028. The Europe market is exhibiting a CAGR of 7.3% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 9% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/blepharoplasty-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Sisram Medical Ltd (Fosun Pharma), AbbVie, Inc., LightScalpel, Inc, Surgical Holdings, GRAND AESPIO, INC., London Bridge Plastic Surgery, Medline Industries, Inc., and Lumenis Be Ltd.
By Type
By Gender
By End User
By Geography
Companies Profiled
Unique Offerings 
